FDA-approved thrombectomy devices selected patients with occlusion of proximal Background. Endovascular thrombectomy were permitted. vessels in the anterior circulation up to 24 h has been proven eﬀective in the ﬁrst 6 h after This trial was also terminated early after suspected onset of symptoms. onset of stroke and large-vessel occlusion in for eﬃcacy after 182 patients had un- Conclusion. Thrombectomy was shown to the anterior cerebral circulation. To date, it dergone randomization. Thrombectomy have high eﬃcacy up to 24 h after suspected was not clear whether thrombectomy beyond symptom onset; however, patient selection was associated with a favorable shift in 6 h is also beneﬁcial. is very complex. Early detection of large- Methods. A summary of the prospective the distribution of functional outcomes vessel occlusion is of utmost importance. The DAWN (DWI or CTP Assessment with on the modiﬁed Rankin scale at 90 days cooperation between existing neurovascular Clinical Mismatch in the Triage of Wake-Up and a higher percentage of patients who and Late Presenting Strokes Undergoing networks should be adapted according to were functionally independent, deﬁned Neurointervention with Trevo) and DEFUSE- these new ﬁndings. 3 (Endovascular Therapy Following Imaging as a score on the modiﬁed Rankin scale of
Der Radiologe – Springer Journals
Published: May 28, 2018
It’s your single place to instantly
discover and read the research
that matters to you.
Enjoy affordable access to
over 18 million articles from more than
15,000 peer-reviewed journals.
All for just $49/month
Query the DeepDyve database, plus search all of PubMed and Google Scholar seamlessly
Save any article or search result from DeepDyve, PubMed, and Google Scholar... all in one place.
Get unlimited, online access to over 18 million full-text articles from more than 15,000 scientific journals.
Read from thousands of the leading scholarly journals from SpringerNature, Elsevier, Wiley-Blackwell, Oxford University Press and more.
All the latest content is available, no embargo periods.
“Hi guys, I cannot tell you how much I love this resource. Incredible. I really believe you've hit the nail on the head with this site in regards to solving the research-purchase issue.”Daniel C.
“Whoa! It’s like Spotify but for academic articles.”@Phil_Robichaud
“I must say, @deepdyve is a fabulous solution to the independent researcher's problem of #access to #information.”@deepthiw
“My last article couldn't be possible without the platform @deepdyve that makes journal papers cheaper.”@JoseServera